In a recent study, researchers found that androgen maintenance therapy for acute myeloid leukemia (AML) led to significantly longer survival in older patients. This is promising news for AML patients, as more than 70% of patients are over the age of 60 when they are diagnosed. AML has been linked to benzene exposure, one of the most widely used chemicals in America.
Today, the main...










